Sentinel Lymph Node Mapping: How Fluorescence-Guided Surgery Works

Sentinel lymph node mapping is a surgical technique that helps doctors identify the first lymph node or nodes most likely to receive drainage from a tumor. Fluorescence-guided imaging can make this process more precise, supporting accurate staging while helping many patients avoid more extensive lymph node surgery.

Overview: What Sentinel Lymph Node Mapping Means

Sentinel lymph node mapping is a method used during cancer surgery to find the first lymph node, or first small group of lymph nodes, that drains fluid from the area of a tumor. These nodes are called sentinel nodes because they are the most likely place for cancer cells to travel first if spread has begun through the lymphatic system. By identifying and testing these nodes, doctors can learn important information about whether cancer has reached nearby lymph nodes.

This approach is different from removing a larger group of lymph nodes routinely. In many patients, if the sentinel nodes do not contain cancer, more extensive lymph node surgery may not be necessary. That can help reduce the risk of complications while still providing accurate staging information. The technique is most established in cancers such as breast cancer, melanoma, and several gynecologic cancers.

Fluorescence-guided surgery adds another layer of precision. A fluorescent dye, most commonly indocyanine green, is injected near the tumor site. Surgeons then use a special camera system that detects near-infrared light to visualize lymphatic channels and sentinel nodes during the operation. This can make the nodes easier to locate in real time and may improve confidence during surgery.

How Fluorescence-Guided Surgery Works

The lymphatic system is a network of vessels and nodes that helps the body manage fluid balance and immune defense. Cancer cells can sometimes enter these channels and move to nearby lymph nodes. Sentinel mapping is based on the idea that lymphatic drainage often follows a predictable path, beginning with one or a few key nodes.

Before or during surgery, the surgeon injects a mapping agent around the tumor or in nearby tissue. Depending on the cancer type and the hospital’s protocols, this may include a blue dye, a radioactive tracer, a fluorescent dye such as indocyanine green, or a combination of these. With fluorescence-guided surgery, a near-infrared camera highlights the dye as it moves through lymphatic vessels, allowing the surgeon to follow the pathway and identify the target node.

Once the sentinel node is found, it is removed and sent for pathological examination. A pathologist checks the tissue for cancer cells using standard microscopic evaluation and, when needed, additional staining methods. The results help guide staging and treatment planning. In some settings, surgeons may combine sentinel mapping with biopsy techniques and advanced oncology care planning as part of a broader cancer treatment pathway.

Fluorescence guidance does not replace the skill of the surgical team. Instead, it works as an imaging tool that can improve visualization, especially in areas where lymphatic anatomy is complex or where a less invasive approach is preferred.

When It Is Used and Why It Matters

Sentinel lymph node mapping is commonly used when doctors need to know whether cancer has spread to nearby lymph nodes but want to avoid unnecessary removal of many nodes. It plays an important role in staging, which is the process of describing how far a cancer has spread. Accurate staging helps the care team decide whether additional surgery, radiation therapy, chemotherapy, immunotherapy, or hormone therapy may be needed.

The technique is widely used in breast cancer surgery and in melanoma. It is also increasingly used in selected gynecologic cancers such as endometrial and cervical cancer. In some centers, fluorescence-guided mapping may be incorporated into cancer surgery workflows to support minimally invasive and targeted approaches.

The main benefit for many patients is that fewer lymph nodes may need to be removed if the sentinel nodes are negative. This can lower the chance of long-term side effects such as swelling of the arm or leg, stiffness, numbness, or reduced range of motion. For patients, that can mean an easier recovery without giving up important diagnostic information.

Sentinel mapping is not appropriate in every situation. If cancer is already clearly present in multiple lymph nodes, if lymphatic drainage has been altered by earlier surgery, or if the tumor type does not reliably follow sentinel node patterns, doctors may recommend a different surgical plan.

Potential Benefits and Limitations

One of the clearest advantages of sentinel lymph node mapping is that it can make surgery more selective. Instead of removing many nodes to look for spread, the surgeon focuses on the nodes most likely to be involved first. This often means a smaller operation, less disruption to normal tissues, and a lower risk of some complications.

Fluorescence-guided imaging may offer practical benefits in the operating room. It provides real-time visualization, can help detect lymphatic channels that are hard to see with the naked eye, and may improve node detection in certain cancers and body regions. The technology can be particularly helpful in minimally invasive procedures, where direct tactile feedback is limited.

Still, no mapping method is perfect. In some patients, the sentinel node cannot be identified, or the drainage pattern may be unusual. There is also a small chance of a false-negative result, meaning the sentinel node appears free of cancer even though cancer has spread elsewhere. For that reason, sentinel node findings are always interpreted alongside imaging, tumor features, and the overall clinical picture.

Patients should also know that this procedure is mainly a diagnostic and staging tool. It helps answer an important question about cancer spread, but it does not by itself treat all cancer in the body. The final treatment plan depends on the pathology results and the recommendations of the multidisciplinary team.

What Patients Can Expect Before, During, and After the Procedure

Preparation depends on the type of cancer and the planned operation. Some patients have mapping injections shortly before surgery, while others may have them in a nuclear medicine or operating room setting. The surgeon will explain where the dye or tracer will be injected and whether more than one mapping method will be used.

During surgery, the team uses the imaging system to trace lymphatic drainage and find the sentinel node or nodes. These nodes are carefully removed through the same operation used to treat the primary tumor, or through a small additional incision if needed. The rest of the surgery proceeds according to the cancer type and the agreed surgical plan.

After the operation, patients may notice mild soreness, bruising, or temporary discoloration if blue dye was used. Recovery is often easier than after more extensive lymph node dissection, although this varies from person to person. Results from the pathology examination are usually discussed at a follow-up visit, where the doctor explains what was found and what it means for staging and next steps.

It is helpful for patients to ask in advance how the pathology report may affect treatment decisions. For example, the results may influence whether additional surgery is needed, whether radiation is recommended, or whether systemic treatments should be considered.

Safety, Risks, and Possible Side Effects

Sentinel lymph node mapping is generally considered safe when performed by experienced teams. Even so, like any surgical procedure, it has possible risks. These include bleeding, infection, discomfort at the incision site, and reactions to the dyes or tracers used for mapping. Allergic reactions are uncommon, but the care team checks medical history carefully before the procedure.

One reason this technique is valued is that it may reduce the risk of lymphedema compared with removal of many lymph nodes. Lymphedema is swelling caused by disruption of normal lymph drainage. The risk is not zero, but it is usually lower when fewer nodes are removed. Some patients may also experience temporary numbness, tingling, or stiffness near the surgical area.

Fluorescence-guided surgery itself does not expose patients to the same type of ionizing radiation used in X-rays or CT scans. However, some sentinel mapping protocols use a radioactive tracer in addition to fluorescence. If so, the surgical team explains the purpose and the safety precautions. These tracers are used in very small, carefully controlled amounts.

Patients should tell their doctor about any history of dye reactions, liver disease, pregnancy, breastfeeding, or other important medical conditions. That information helps the team choose the safest mapping strategy for the individual patient.

Questions to Discuss With the Surgical Team

Patients often feel more comfortable when they understand why sentinel mapping is being recommended and what alternatives exist. Useful questions include whether the procedure is appropriate for the specific cancer type, whether fluorescence guidance will be used, and what the possible outcomes may mean for treatment. Asking how often the center performs this technique can also be helpful.

It is also reasonable to ask what happens if the sentinel node cannot be found or if cancer is detected in it. In some cases, no further lymph node surgery is needed, while in others additional treatment may be recommended based on the latest evidence and guidelines. The answer depends on the tumor type, the amount of nodal involvement, and the patient’s overall treatment plan.

Patients who are receiving care across specialties may benefit from a multidisciplinary discussion involving surgical oncology, medical oncology, radiation oncology, pathology, and imaging experts. Near the end of the care journey, centers such as Acibadem International may support international patients with multidisciplinary assessment in JCI-accredited hospitals for diagnosis and treatment planning.

If there is uncertainty about diagnosis or staging, the team may also recommend related evaluations such as imaging or targeted tissue sampling. In some cases, additional assessment may be connected with PET-CT or other diagnostic steps, depending on the cancer type and the clinical question being asked.

Frequently asked questions

Is sentinel lymph node mapping the same as removing all lymph nodes?

No. Sentinel lymph node mapping focuses on finding and removing the first node or few nodes most likely to receive drainage from the tumor area. This is often different from a full lymph node dissection, which removes many more nodes.

What is the fluorescent dye used in fluorescence-guided surgery?

A commonly used dye is indocyanine green, which becomes visible with a near-infrared camera system. It helps surgeons see lymphatic channels and sentinel nodes during the operation. The exact mapping method may vary by cancer type and hospital protocol.

Does a negative sentinel lymph node mean the cancer has definitely not spread?

A negative sentinel node strongly suggests there is no nearby lymph node spread, but no test is perfect. Doctors interpret the result together with imaging, pathology, tumor features, and the overall clinical picture. This combined approach helps guide the safest treatment plan.

Which cancers commonly use sentinel lymph node mapping?

It is most commonly used in breast cancer and melanoma. It is also used in selected gynecologic cancers, such as endometrial and cervical cancer, and may be considered in other situations depending on the center's expertise and current guidelines.

Is sentinel lymph node mapping painful?

The procedure itself is usually done as part of surgery, so patients do not feel it during the operation. Some people may feel temporary discomfort from the injection site or mild soreness afterward. The care team provides guidance on pain control and recovery.

Can fluorescence-guided surgery reduce complications?

It may help surgeons identify lymphatic pathways and target nodes more precisely, which can support a more selective operation. When fewer lymph nodes are removed, the risk of some side effects, such as lymphedema, may be lower in appropriate patients. However, the benefit depends on the cancer type and the individual case.

References

• National Cancer Institute
• American Cancer Society
• National Comprehensive Cancer Network
• Society of Surgical Oncology
• World Health Organization

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.